77 related articles for article (PubMed ID: 23651415)
1. Haptoglobin phenotypes and in vitro fertilization treatment outcomes.
Weiss A; Ozeri D; Beck-Fruchter R; Lavee M; Geslevich Y; Levy AP
Syst Biol Reprod Med; 2013 Oct; 59(5):281-4. PubMed ID: 23651415
[TBL] [Abstract][Full Text] [Related]
2. In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities".
Hourvitz A; Maman E; Brengauz M; Machtinger R; Dor J
Fertil Steril; 2010 Jul; 94(2):496-501. PubMed ID: 19589517
[TBL] [Abstract][Full Text] [Related]
3. Involvement of phenotypes and serum levels of haptoglobin in the outcome of in vitro fertilization and embryo transfer.
Ueda K; Yamamasu S; Nakamura Y; Honda K; Ozaki K; Fujino Y; Ishiko O; Ogita S
Gynecol Obstet Invest; 2001; 51(4):219-22. PubMed ID: 11408730
[TBL] [Abstract][Full Text] [Related]
4. [Outcomes of in vitro fertilization-embryo transfer and intracytoplasmic sperm injection for non-male infertility patients with a low number of oocytes retrieved].
Tan H; Chen L; He L; Quan S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):251-4. PubMed ID: 22381770
[TBL] [Abstract][Full Text] [Related]
5. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
6. Haptoglobin phenotype and risk of cervical neoplasia: a case-control study.
Mahmud SM; Koushik A; Duarte-Franco E; Costa J; Fontes G; Bicho M; Coutlée F; Franco EL;
Clin Chim Acta; 2007 Oct; 385(1-2):67-72. PubMed ID: 17706188
[TBL] [Abstract][Full Text] [Related]
7. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
Reichman DE; Chung P; Meyer L; Greenwood E; Davis O; Rosenwaks Z
Fertil Steril; 2013 Apr; 99(5):1277-82. PubMed ID: 23290740
[TBL] [Abstract][Full Text] [Related]
8. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
9. Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia.
Sertório JT; Lacchini R; Amaral LM; Palei AC; Cavalli RC; Sandrim VC; Duarte G; Tanus-Santos JE
J Hum Hypertens; 2013 Jun; 27(6):349-54. PubMed ID: 23223086
[TBL] [Abstract][Full Text] [Related]
10. Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.
Vormittag R; Vukovich T; Mannhalter C; Minar E; Schönauer V; Bialonczyk C; Hirschl M; Pabinger I
Haematologica; 2005 Nov; 90(11):1557-61. PubMed ID: 16266904
[TBL] [Abstract][Full Text] [Related]
11. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
[TBL] [Abstract][Full Text] [Related]
12. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
13. In vitro fertilization is a successful treatment in endometriosis-associated infertility.
Opøien HK; Fedorcsak P; Omland AK; Abyholm T; Bjercke S; Ertzeid G; Oldereid N; Mellembakken JR; Tanbo T
Fertil Steril; 2012 Apr; 97(4):912-8. PubMed ID: 22341637
[TBL] [Abstract][Full Text] [Related]
14. Efficiency of oocyte cryopreservation: a meta-analysis.
Oktay K; Cil AP; Bang H
Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
[TBL] [Abstract][Full Text] [Related]
15. Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes?
Goldenberg-Cohen N; Gabbay M; Dratviman-Storobinsky O; Reich E; Axer-Siegel R; Weinberger D; Gabbay U
Retina; 2011 Sep; 31(8):1574-80. PubMed ID: 21555971
[TBL] [Abstract][Full Text] [Related]
16. Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization.
Suzuki T; Izumi S; Matsubayashi H; Awaji H; Yoshikata K; Makino T
Fertil Steril; 2005 Apr; 83(4):908-13. PubMed ID: 15820799
[TBL] [Abstract][Full Text] [Related]
17. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
Ye H; Huang G; Pei L; Zeng P; Luo X
Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
[TBL] [Abstract][Full Text] [Related]
18. Smoking and the correlation between birth weight and placental weight. Evidence of interaction with maternal haptoglobin phenotype.
Gloria-Bottini F; Bottini E
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():136-9. PubMed ID: 25575141
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization.
Melo M; Bellver J; Garrido N; Meseguer M; Pellicer A; Remohí J
Fertil Steril; 2010 Aug; 94(3):958-64. PubMed ID: 19931075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
